[A meta-analysis of the safety of simultaneous versus staged resection for synchronous liver metastasis from colorectal cancer]

Zhonghua Wei Chang Wai Ke Za Zhi. 2010 May;13(5):337-41.
[Article in Chinese]

Abstract

Objective: To evaluate the safety of simultaneous and staged resection for synchronous liver metastasis from colorectal cancer.

Methods: PubMed/Medline, ISI Web of Knowledge, Springer link, ebscohost, Elsevier Wiley Interscience, Google Scholar were searched for case-control studies concerning simultaneous versus staged resection of synchronous liver metastasis from colorectal cancer between January 1989 and March 2009. A meta-analysis was performed to analyze the morbidity and perioperative mortality.

Results: Seven case-control studies, with a total of 1390 patients of liver metastasis from colorectal cancer undergone curative hepatic resection, were reviewed. There were 495 simultaneous and 895 staged resections. Perioperative mortality was 1.1% in the staged resection group and 2.4% in the the simultaneous group, the difference was statistically significant[Peto OR 3.39, 95% CI 1.29-8.93, P=0.01]. No significant difference was found in morbidity between two groups[OR(random)0.88, 95% CI 0.51-1.51, P=0.64].

Conclusion: Selective staged resection is safe for synchronous liver metastasis from colorectal cancer.

Publication types

  • Evaluation Study
  • Meta-Analysis

MeSH terms

  • Colorectal Neoplasms / pathology*
  • Colorectal Neoplasms / surgery
  • Hepatectomy*
  • Humans
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / surgery*
  • Neoplasm Staging